According to The New York Times, Lonvi Biosciences, a startup based in Shenzhen, China, is working on a new biotechnology drug aimed at dramatically extending life expectancy, meaning humans can live up to 120 years.
According to the company's specialists, the main substance of the drug is a natural extract obtained from grape seeds. These compounds destroy "outdated" cells that appear in the body during aging and restore the function of healthy cells. This method aims not only to increase life expectancy, but also its quality and activity.
It is noted that grape seeds have been famous for their ability to preserve youth and improve blood circulation in traditional Chinese medicine and Western dietary science for centuries. Lonvey Biosciences has found a way to convert this natural substance into high-concentration molecules.
The company is already conducting the initial stage of clinical trials. They say that if the new capsules are combined with a healthy lifestyle, proper nutrition, and regular medical supervision, there is a high probability of extending human life by 100-120 years.
Experts emphasize that such an innovation can change the worldview that perceives aging as a natural process and can usher in a new era in biotechnology.
Read “Zamin” on Telegram!
